Stocks and Investing Stocks and Investing
Thu, July 6, 2023

Roy Buchanan Reiterated (ABUS) at Buy and Held Target at $6 on, Jul 6th, 2023


Published on 2024-10-28 04:39:21 - WOPRAI, Roy Buchanan
  Print publication without navigation


Roy Buchanan of JMP Securities, Reiterated "Arbutus Biopharma Corporation" (ABUS) at Buy and Held Target at $6 on, Jul 6th, 2023.

Roy has made no other calls on ABUS in the last 4 months.



There are 2 other peers that have a rating on ABUS. Out of the 2 peers that are also analyzing ABUS, 0 agree with Roy's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Roy


  • Ed Arce of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $6 on, Thursday, June 22nd, 2023
  • Keay Nakae of "Chardan Capital" Reiterated at Strong Buy and Held Target at $6 on, Thursday, June 22nd, 2023
Contributing Sources